Remove topic clinical-trial-services
article thumbnail

Virtual Patient Engagement Programs

Impetus Digital

Our best-in-class technology and professional services ensure that life science organizations around the world can easily and cost-effectively grow and prosper—from brand or idea discovery to development, commercialization, execution, and beyond—in collaboration with colleagues, customers, healthcare providers, payers, and patients.

article thumbnail

EMA CHMP recommends Moderna’s Covid-19 booster for children

Pharmaceutical Technology

The EMA positive opinion is based on clinical findings of mRNA.1273.214, Moderna’s paediatric application is based on clinical trial booster findings for Spikevax, the company’s original vaccine. Additionally, the application included findings from a Phase II/III clinical trial of mRNA-1273.214. 5), mRNA-1273.

Medicine 121
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New facility boosts UK’s cell and gene therapy manufacturing capacity

Pharmaceutical Technology

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. In the past, researchers have often had to seek help from outside the UK, thus delaying clinical trials and patient access.

article thumbnail

Genenta Science signs manufacturing service deal with AGC Biologics

Pharmaceutical Technology

Genenta Science and AGC Biologics have signed a development and manufacturing service agreement (MSA). Under the deal, AGC Biologics will be responsible for manufacturing the cell therapy lentivirus-based product for the ongoing clinical programmes of Genenta Science.

article thumbnail

Looking back at 2022: The top healthcare stories

Pharmaceutical Technology

Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced. Russia’s war on Ukraine dealt a blow to healthcare services in the area that had far-reaching ramifications. Still, the country’s clinical trials sector remains insular.

article thumbnail

Incannex engages QPS for CannQuit and ReneCann

Pharmaceutical Technology

Australian pharmaceutical company Incannex has appointed Quest Pharmaceutical Services (QPS) to advance CannQuit-N (Nicotine), CannQuit-O (Opioid) and Renecann Products in the USA and the European Union (EU). QPS was established in 1995 to provide bioanalytical LC-MS/MS contract services.

article thumbnail

Moderna and UK government sign deal to establish mRNA facility

Pharmaceutical Technology

The vaccine manufacturing facility will also offer National Health Service (NHS) patients access to the company’s Covid-19 vaccines that can provide protection against various variants. Topic sponsors are not involved in the creation of editorial content. Free Whitepaper. Optimise your cell therapy process: a guide to cell thawing.